Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FRRN4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,517
Award facts
- Contract value 100% obligated
- $11,516.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $11,516.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of BOTOX 100 unit vials. The delivery order was issued on January 23, 2026, with an ultimate completion date of February 13, 2026, and carries no set-aside designation. This award represents a competitive procurement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group was established as a prime vendor contractor under the PPV-G GEN V acquisition strategy, a $30.3 billion federal pharmaceutical supply initiative that enables the DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support military healthcare facilities worldwide. The vendor's appointment as a regional prime contractor reflects its demonstrated capability to supply specialized pharmaceutical products, including branded and generic medications, biologics, and medical supplies to Department of Defense healthcare operations. This delivery order for BOTOX represents a routine pharmaceutical procurement issued against the company's broader $499.9 billion IDC ceiling, which extends through December 31, 2036.
Quick answers
Who was awarded contract SPE2DR26FRRN4?
SPE2DR26FRRN4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FRRN4 worth?
The government has obligated $11,517 on SPE2DR26FRRN4.
Is contract SPE2DR26FRRN4 an order under another contract?
Yes. SPE2DR26FRRN4 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRN4 competed?
The extent of competition for SPE2DR26FRRN4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award